Their findings revealed elevated levels of urinary SPON2 in patients with type 2 diabetes compared to healthy individuals, suggesting its potential as an early biomarker for monitoring the progression of DN (48, 49). This evidence concerns the gene SPON2 and liver dysplastic nodule.